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INTRODUCTION 
 
 Hypertension is one of the leading causes of death and disability among adults all 
over the world. It remains the major risk factor for coronary, cerebral and peripheral 
vascular disease. Essential hypertension comprises more than 90% of hypertension (1). 
 
 Hypertension is an emerging health problem in India. When majority of people 
come to know that they have hypertension they have already advanced into a stage with 
target organ damage – a fatal stroke or myocardial infarction or irreversible renal failure. 
Unfortunately even in developed countries like United States, fifty million people are 
found to have hypertension. Of these, 70% are aware of their diagnosis, but only 50% are 
receiving treatment and only 25% are under control (2). 
 
 In addition to a primary increase in cardiac function propelled by overactive 
sympathetic nervous system, primary retention of salt and water by kidney, other factors 
contributing to hypertension are hereditary predisposition and high sodium and low 
potassium intake and excretion. 
 
 In a country like India, people used to have a diet rich in sodium and poor in 
potassium. Many studies have shown that a positive correlation exists between serum 
sodium and blood pressure and a negative correlation exists between serum potassium 
and blood pressure. They have shown that a decreased intake of sodium and increased 
potassium intake or both together may be effective in prevention or even treatment of 
hypertension. Independent reports on serum sodium and potassium among Indian 
hypertensive population were lacking and hence the present study was conducted. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
REVIEW OF LITERATURE 
 
ESSENTIAL HYPERTENSION: 
 An elevated arterial pressure is one of the most important public health problems 
and despite it’s widely recognized high prevalence and associated danger, it remains 
inadequately treated in majority of the patients. It is common, readily detectable, and 
usually easily treatable and if left untreated can lead to serious morbidity and mortality 
from cardiac, cerebrovascular, vascular and renal disease. Adequate hypertension control 
remains elusive because of the asymptomatic nature of the disease for the first 15 – 20 
years even as it progressively damages the cardiovascular system (3). Although our 
understanding of the pathophysiology of hypertension has increased in 90% to 95% of 
cases, etiology is still mostly unknown (4). 
 
Definition and classification: 
 Blood pressure is distributed in a typical bell shaped curve within the overall 
population. As seen in the Multiple Risk Factor Intervention Trial (MRFIT), the long 
term risks for cardiovascular mortality rise progressively over the entire range of blood 
pressure, with no threshold that clearly identifies the potential danger. Therefore the 
definition of hypertension is somewhat arbitrary and usually taken as that level of 
pressure associated with doubling of long term risks. 
 
 According to JNC (Joint National Committee) 7 report, in adults aged18 years 
and above, systolic blood pressure of <120 mm of Hg and diastolic blood pressure of <80 
mm of Hg is normal. Systolic blood pressure of 120 – 139 mm of Hg and diastolic blood 
pressure of 80 – 89 mm of Hg is prehypertension. In stage I hypertension, the systolic 
blood pressure is 140 – 159 mm of Hg and diastolic blood pressure is 90 – 99 mm of Hg. 
In stage II hypertension, systolic blood pressure is ≥ 160 mm of Hg and diastolic blood 
pressure is ≥ 100 mm of Hg (5). 
 
Table – I 
JNC 7 Classification of Blood Pressure for Adults ≥ 18 years* 
Sl. No. Category 
Systolic BP 
(mm of Hg) 
 
Diastolic BP 
(mm of Hg) 
1. Normal <120 and <80 
2. Prehypertension 120-139 or 80-89 
Hypertension 
Stage I 
 
140-159 
 
or 
 
90 -99 3. 
Stage II ≥160 or ≥100 
 
* ( Source, JAMA 2003; 289:2560) 
 
Prevalence: 
 Cardiovascular diseases account for a large proportion of all deaths and disability 
worldwide. In 1990 there were 5.2 million deaths from cardiovascular diseases in 
economically developed countries and 9.1 million deaths from the same causes in 
developing countries. In 1990 in India, out of 9.4 million total deaths, cardiovascular 
diseases caused 2.3 million deaths (25%), 1.2 million deaths were due to coronary heart 
disease and 0.5 million were due to stroke(6). It has been predicted that by 2020, there 
would be a 111% increase in cardiovascular deaths in India. Hypertension is a major 
cardiovascular risk factor and important public health problem in the Indian subcontinent 
and among the South Asians world-wide (7, 8). 
 
 Hypertension is directly responsible for 57% of all stroke deaths and 24% of all 
coronary heart disease deaths. This fact is important because hypertension is a 
controllable disease and a 2 mm Hg population-wide decrease in blood pressure can 
prevent 151,000 stroke and 153,000 coronary heart disease deaths in India (9, 10). 
 
The average BP levels in China were systolic: 118±18 mm Hg and diastolic: 
76.6±11 mm Hg in a sample of 10,076 urban and rural subjects 35-54 years of age. In 
India Gupta et al reported mean systolic BP (men: rural 127±14, urban 125±17; women: 
rural 124±13, urban 126±18) and diastolic BP (men: rural 81±8, urban 81±9; women: 
rural 80±8, urban 81±12) levels in western Indian urban and rural subjects aged ≥20 years 
(11). Systolic BP has increased in Indian men aged 40-49 years from 123±11 mm Hg in 
1959 to 128.8±17 mm Hg in 1995(12). 
 
Recent studies among Indians have shown a high prevalence of hypertension in 
both urban and rural areas (13, 14). The prevalence rate of hypertension in India done by 
various study groups is shown in the Table – II given in the next page. 
 
Table - II 
Recent Indian Hypertension Prevalence Studies (BP >140/90) # 
 
Sample size 
 
 
Prevalence (%) 
 
First author 
Age 
group 
 
Place 
Men Women Men Women 
Gupta R 
 
1995 
20-75 Jaipur 1415 797 29.5 33.5 
Joseph A 
 
2000 
20-89 Trivandrum 76 130 31 41.2 
Anand MP 
 
2000 
30-60 Mumbai 1521 141 34.1* - 
Mohan V 
2000 
20-70 Chennai 518 657 14* - 
Gupta R 
2002 
20-75 Jaipur 550 573 36.4 37.5 
Gupta PC 
2004 
18-60 Mumbai 40067 59522 43.8 44.5 
* Gender specific data not available 
# (Source, J Human Hypertension 2004; 18: 73-78) 
Awareness status of hypertension in India is poor. In urban population of Mumbai 
there was a very low awareness of hypertension and only 6.1% males and 10.1% females 
were aware of the hypertension in early 1990`s (15). In Jaipur also it has been reported 
that only 11% of male and 16% of female hypertensives were aware of their condition 
(16). Higher awareness of hypertension has been reported among the more educated 
populations in Kerala and among Parsis in Mumbai (17, 18). In community dwelling 
elderly individuals in Kerala (n= 357, mean age 70 years) hypertension was present in 
51.8% subjects and 44.9% of these individuals were aware of their condition (17). 
Bharucha and Kuruvilla (18) reported that 53% of men and 44% of women were unaware 
of their hypertensive status although 905 had their BP measurement in their past. This 
level of awareness is similar to reported from many developed countries and shows that 
within India there is a wide variation in hypertension awareness status. 
 
Natural History and Complications: 
The pathological hallmark of untreated hypertension is acceleration of 
atherosclerosis. The higher the BP, the more likely that various cardiovascular diseases 
will develop prematurely. If untreated, 50% of the hypertensive patients die of coronary 
artery disease or congestive cardiac failure, about 33% of stroke and 10 – 15% of renal 
failure. A meta-analysis of nine major prospective studies shows a direct continuous and 
apparently independent association of diastolic BP with both coronary artery disease and 
stroke (19).  
 
In general the vascular complications of hypertension can be considered as either 
hypertensive or atherosclerotic. 
 
I. Hypertensive Complications: 
1. Accelerated malignant phase 
2. Hemorrhagic stroke 
3. Congestive heart failure 
4. Nephrosclerosis 
5. Aortic dissection 
 
II. Atherosclerotic Complications: 
1. Coronary artery disease 
2. Sudden death 
3. Arrhythmias 
4. Atherothrombotic Stroke 
5. Peripheral vascular stroke 
 
Overall Cardiovascular Risk: 
 The degree of risk from hypertension can be categorized with reasonable accuracy 
by taking into account 
1. The level of Blood Pressure. 
2. The biological nature of hypertension based on target organ damage. 
3. The co-existence of other cardiovascular risk factors (20). 
 The goal of anti-hypertensive therapy should not only be the reduction of blood 
pressure but also treating other risk factors. The major cardiovascular risk factors 
indicated in JNC-7 report are 
 
1. Hypertension 
2. Cigarette smoking 
3. Obesity  
4. Physical inactivity 
5. Dyslipidemia 
6. Diabetes mellitus 
7. Microalbuminuria or estimated GFR <60 ml/min 
8. Age (>55 for men, >65 for women). 
9. Family history of premature cardiovascular disease (<55 for men, <65 
for women) 
 
Systolic Hypertension and Pulse Pressure: 
 Systolic blood pressure rises in a linear fashion with age, where as diastolic blood 
pressure increases until the age of fifty then levels off and even begins to fall. Isolated 
diastolic hypertension is more common in younger subjects, while isolated systolic 
hypertension emerges as the most common form of hypertension in the elderly. The 
underlying pathological process is loss of arterial elastic tissue, which means that the 
pressure was created by left ventricular contraction, can no longer be damped by the aorta 
and major vessels. Systolic blood pressure is a better predictor of cardiovascular risk and 
isolated systolic hypertension is now recognized to be an independent risk factor of 
cardiovascular disease. A wide pulse pressure has a similar influence on    prognosis (21). 
 
Gender Differences: 
 Hypertension is an important risk factor for cardiovascular disease in women. 
Although premenopausal women have lower blood pressure than age matched men, the 
prevalence of hypertension is higher in women than men after the age of sixty five. 
Obesity is significantly more common in middle aged and older women and is likely to 
contribute to cross over in prevalence. Oral contraceptive pills increase the risk of 
hypertension in younger women. Hormone replacement therapy does not raise the blood 
pressure in women who are normotensive at the start of treatment. 
 
 The ratio of hypertension frequency in women versus men increases from 0.6 to 
0.7 at age 30 to 1.1 to 1.2 at age 65 years. 
 
Hypertension in black populations: 
 Hypertension is most common in black than in white and more common in urban 
than rural blacks. Black individuals have a higher incidence of salt sensitive hypertension 
than white individuals and retain more sodium leading to expanded plasma volumes and 
lower plasma renin activity. The complications of hypertension also tend to be different 
in blacks with a higher incidence of left ventricular hypertrophy, stroke, renal failure and 
lower risk of coronary artery disease. The increased frequency of left ventricular 
hypertrophy and stroke and renal failure is due to severity of hypertension in black and 
lower risk of coronary artery disease than white is due to more favourable lipid profiles. 
 
Mechanisms of Primary Hypertension: 
 No single or specific cause is known for most cases of hypertension, and the 
condition is referred to as primary in preference to essential. Blood pressure is the 
product of cardiac output and peripheral vascular resistance (BP = CO X PVR). Since 
persistent hypertension can develop only in response to an increase in cardiac output or a 
rise in peripheral resistance, defects may be present in one or more of the multiple factors 
that affect these two forces. This can be described under the following headings. 
 
1. Non renal factors 
2. Renal factors 
 
I. Non renal factors: 
 Primary hypertension is a complex multifactorial and polygenic disorder that 
results from an interaction between an individual’s genetic background and various 
environmental factors. 
 
1. Genetic Predisposition: 
In studies of twins and family members in which the degree of familial 
aggregation of blood pressure level is compared with the closeness of genetic sharing, the 
genetic contributions have been estimated to range from 30% to 60% (22). Harrap 
suggested that “the average population blood pressure is determined by the environment 
but the blood pressure rank within the distribution is decided largely by genes (23). 
 
Epidemiological data suggest that for population variability in blood pressure 
genetic factors contribute 30 – 35%, common household environment about 10 – 15% 
and non familial factors for the remaining 50 – 55% (24). 
 
If genetic markers of a predisposition for the development of hypertension are 
found, then specific environmental manipulations could then be directed toward the 
susceptible subjects (25). Pratt, from his observation of bimodal distribution of blood 
pressure in some families with hypertensive subjects, proposed autosomal dominant 
mode of inheritance. Pickering proposed that blood pressure is a quantitative trait with 
genetic contribution which is polygenic. 
 
Genome wide scanning strategy in sib-pairs has identified chromosomal regions 
on chromosomes 6, 5, 12 and 15 which showed significant linkage to genes that 
influences inter individual blood pressure variation. There are several candidate genes 
within the identified group (26). 
 
Polymorphism of genes involving the RAS system, aldosterone synthesis and 
adrenergic receptors has been noted to be more common in the hypertensive than 
normotensive patients (27). Genetic abnormalities may be monogenic in some rare forms 
of hypertension like glucocorticoid remediable aldosteronism, Liddle syndrome, and 
apparent mineralocoricoid excess (28). 
 
2. Fetal environment: 
Low birth weight as a consequence of fetal under nutrition is followed by an 
increased incidence of high blood pressure later in life with an overall estimate that a 1 kg 
lower birth weight is associated with a 2 to 4 mm Hg higher systolic blood pressure in 
adulthood (29). Brenner and Chertow hypothesized that a decreased number of nephrons 
from the intrauterine growth retardation could very well serve as a permanent irreparable 
defect that eventuates in hypertension (30). 
 
3. Vascular Remodeling: 
A number of factors increase peripheral resistance by both functional contraction 
and vascular remodeling and hypertrophy. Multiple vasoactive substances act as 
pressure-growth promoters resulting in both vascular contraction and hypertrophy 
simultaneously, but perpetuation of hypertension involves hypertrophy. Lever and Harrap 
(31) postulated that primary hypertension has two mechanisms similar to secondary 
hypertension (a) a growth promoting process in children, and (b) a self-perpetuating 
mechanism in adults. 
 
 
 
 
4. Neurohumoral causes of primary hypertension: 
A large number of circulatory hormones and locally acting substances may be 
involved in the development of hypertension which causes hypertension by vascular 
hypertrophy, capillary rarefaction and impaired microvascular dilation (32). 
 
A. Sympathetic Nervous Hyperactivity: 
Young hypertensives tend to have increased levels of circulating catecholamines, 
augmented sympathetic nerve traffic in muscles, faster heart rate and heightened vascular 
reactivity to α adrenergic agonists (33). 
 
These changes could raise blood pressure in a number of ways – either alone or in 
concert with stimulation of renin release by catecholamines or by causing arteriolar and 
venous constriction or by increasing cardiac output or by altering the normal renal 
pressure – volume relationship. 
 
B. Renin – Angiotensin System: 
Both as a direct pressor and as a growth promoter, the renin – angiotensin 
mechanism may be also involved in the pathogenesis of hypertension. All functions of 
renin are mediated through the synthesis of angiotensin II. This system is the primary 
stimulus for the secretion of aldosterone and hence mediates minerlocorticoid responses 
to varying sodium intake and volume overload. When sodium intake is reduced or 
effective plasma volume shrinks the increase in renin – angiotensin II stimulates 
aldosterone secretion, which in turn is responsible for a portion of the enhanced renal 
retention of sodium and water. 
 
When large populations of hypertensives are surveyed, only about 30 percent 
have low plasma renin activity levels, where as 50 percent have normal levels and the 
remaining 20 percent have high levels (34). 
 
Normal and high renin hypertension: 
Some persons with primary hypertension have normal or high renin levels. The 
concept of “nephron heterogeneity” (35) descried by Sealy and colleagues, assumes a 
mixture of normal and ischemic nephrons caused by afferent arteriolar narrowing. Excess 
renin from the ischemic nephrons could raise the total blood renin level to varying 
degrees and cause high renin levels in patients with primary hypertension. 
 
C. Hyper insulinemia / Insulin resistance: 
 An association between hypertension and hyperinsulinemia has been recognized 
for many years, particularly with accompanying obesity but also in about 20 percent of 
non obese hypertensive patients (36). The hyperinsulinemia of hypertension arises as a 
consequence of resistance to the effects of insulin on peripheral glucose utilization. This 
association does not apply to pima Indians but it has been found in blacks, Asians and as 
well as whites.  The impairment of the peripheral actions of the insulin result from a 
defect in the usual vasodilatory effect of insulin mediated through increased synthesis of 
nitric oxide, which normally counters the multiple pressor effects of insulin (37). These 
pressor effects include activation of sympathetic activity, a trophic action on vascular 
hypertrophy, and increased renal sodium reabsorption. 
 
 The failure of vasodilation to antagonize the multiple pressor effects of insulin 
presumably eventuates in a rise in blood pressure that may be either a primary cause of 
hypertension or, at least, a secondary potentiator. 
 
D. Endothelial Cell dysfunction: 
 The endothelium is now known to be the source of multiple relaxing and 
contracting substances, of which nitric oxide is an important vasodilator (38). The 
impairment of normal vasodilation in the insulin resistance syndrome has been shown to 
involve failure to synthesize the normal endothelium derived relaxing factor (NO). 
 
Nitric Oxide: 
 Hypertensive patients have been shown to have a reduced vasodilatory response 
to various stimuli of nitric oxide release that appears to be independent of the etiology of 
the hypertension and the degree of the gross vascular structural alteration. Impaired nitric 
oxide mediated vasodilation may promote abnormal vascular remodeling and may be 
involved in the greater propensity for vascular damage in blacks than in whites. Nitric 
oxide – mediated forearm responsiveness has been restored by normalization of blood 
pressure by anti hypertensive drugs with different modes of action. 
 
 
Endothelin: 
 Endothelin – 1 causes pronounced and prolonged vasoconstriction and because 
blockade of its receptors improves endothelium – dependent vasodilation in hypertensive 
patients (39). 
 
E. Minerals: 
 Excess of lead and changing ratios among dietary sodium, potassium, calcium and 
magnesium have also been postulated in the pathogenesis of primary hypertension (40). 
 
II. Renal retention of excess dietary sodium: 
 A considerable amount of circumstantial evidence supports a role for sodium in 
the genesis of hypertension. To induce hypertension, some of the excess sodium must be 
retained by the kidneys. Such retention could arise in a number of ways. 
 
1. Nephron heterogeneity, described as the presence of a sub population of 
nephrons that is ischemic either from afferent arteriolar vasoconstriction or from an 
intrinsic narrowing of the lumen. Renin secretion from this sub group of nephrons is 
tonically elevated. This increased renin secretion then interferes with the compensatory 
capacity of intermingled normal nephrons to adaptively excrete sodium and 
consequently, over all blood pressure homeostasis (35). 
 
2. A decrease in the filtration surface by a congenital or acquired deficiency in 
nephron number or function. 
3. A resetting of the normal pressure – natriuresis relationship – the Guyton 
hypothesis (41). 
 
4. An acquired inhibitor of the sodium pump or other abnormalities in sodium 
transport (42). 
 
5. Defensive responsiveness to atrial natriuretic hormones (43). 
 
Association of hypertension with other conditions: 
1. Physical inactivity: 
 Physical fitness may help prevent hypertension and persons who are already 
hypertensive may lower their blood pressure by means of regular isotonic exercise. The 
relation ship may involve insulin resistance because an increased resistance was coupled 
with low physical fitness in normotensive men with a family history of hypertension. 
 
2. Alcohol: 
 Alcohol in larger amounts (more than two portions a day and more so when drunk 
in binges) increases blood pressure and arterial stiffness. The pressure effect of larger 
amount of alcohol reflects an increase in cardiac output and heart rate, possibly a 
consequence of increased sympathetic nerve activity. Alcohol also alters cell membranes 
and allows more calcium to enter, perhaps by inhibition of sodium transport. 
 
 Alcohol in small amounts (less than one or two usual portions a day) provides 
protection from coronary disease, congestive heart failure, stroke, and dementia (44). 
And at least in women, reduces the incidence of hypertension (45). The reduction in 
coronary disease in persons who ingest small amounts of alcohol may reflect an 
improvement in lipid profile, a reduction in factors that encourage thrombosis, and an 
improvement in insulin sensitivity. 
 
 Framingham study showed small overall correlation between alcohol intake and 
blood pressure, but prevalence of hypertension was about two times higher among 
persons drinking sixty ounce or more of ethyl alcohol per month than among those 
drinking less than thirty ounce per month (46). 
 
3. Smoking: 
Cigarette smoking raises blood pressure, probably through the nicotine induced 
release of norepinephrine from adrenergic nerve endings. In addition, smoking causes an 
acute and marked reduction in radial artery compliance independent of the increase in 
blood pressure. When smokers quit, a rise in the blood pressure may occur, probably 
reflecting a gain in weight. Numerous studies have shown that smokers are thinner than 
non smokers and that smoking reduces weight. However they will have larger waist hip 
ratio than non smokers (47). 
 
 
 
4. Hematological Findings: 
Higher hematocrits are found in hypertensive persons and are associated with 
abnormal left ventricular filling on echocardiography (48). Whole blood viscosity in 
increased by about 10 percent in persons with untreated mild hypertension, comparable to 
the increase in their peripheral resistance (49). Pseudo or stress polycythemia with high 
hematocrit and increased blood viscosity but contracted plasma volume, as well as 
normal red cell mass and serum erythropoietin levels are found in hypertension. High 
WBC count is predictive of the hypertension (50). 
 
5. Hyperuricemia: 
Hyperuricemia is present in 25 percent of individuals with untreated hypertension, 
more than 75% of patients with malignant hypertension which are about five times the 
frequency found in normotensive persons (51). Hyperuricemia probably reflects 
decreased renal blood flow, presumably a reflection of nephrosclerosis. 
 
6. Sleep Apnea: 
Snoring and sleep apnea are often associated with hypertension, which may in 
turn be induced by the increased sympathetic activity and endothelin release in response 
to hypoxemia during apnea (52). 
 
7. Hypercholesterolemia: 
Hypercholesterolemia frequently coexists with hypertension, at least in part 
because it impairs endothelium – dependent vasodialtion. Lipid lowering therapy restores 
the bioavailability of nitric oxide, reduces arterial stiffness, and lowers blood pressure 
(53). 
 
8. Obesity: 
The majority of patients with high blood pressure are overweight and 
hypertension is about six times more common than it is in lean subjects (54).  
 
A 10 kg higher body weight is associated with a 3 mm Hg higher systolic and 2.3 
mm Hg higher diastolic blood pressure. These increases translate into an estimated 12% 
increase in the risk of coronary artery disease and 2.24% increase in the risk of stroke. 
 
Body mass index in widely used as a correlation with excess body fat or adiposity 
but it does not convey information on required fat distribution. Body fat distribution plays 
a role as a risk factor for hypertension. An increase in waist hip ratio (WHR) > 0.95 in 
male and 0.8 in female is an independent risk factor for the development of hypertension 
and is independently associated with hypertriglyceride and increased apoprotein – B. The 
waist circumference may be the better indicator of visceral fat than waist hip ratio. 
 
Hip circumference – It is measured at the point of one third of the distance between the 
anterior superior iliac spine and the patella. 
 
Waist Circumference – It is measured half way between superior iliac crest and rib cage 
in mid axillary line. It correlates well with the systolic blood pressure and diabetes 
mellitus. 
 
Body mass index   =    weight in kg   /   height in m². 
 
Table - III 
Proposed classification of weight by BMI in adult Asians (55) * 
Classification BMI  (kg / m²) 
Underweight <18.5 
Normal range 18.5 – 22.9 
Over weight 23 
At risk 23 – 24.9 
Obese I 25 – 29 
Obese II >30 
 
  * (Source, Am J Clin Nutr. 2000; 72: 1067-1068) 
 
Metabolic syndrome: 
 According to ATP III, metabolic syndrome is defined as a cluster of 
cardiovascular risks in a silver individual – normally hypertension, diabetes mellitus, 
abdominal obesity, low HDL, increased TGL, procoagulant tendency and increased small 
LDL. 
 Obese individuals with high waist hip ratio have high incidence of hypertension 
than do with low waist hip ratio (56). Visceral obesity is a strong risk factor for 
hypertension. Although body mass index is a very strong determinant of blood pressure, a 
visceral distribution of fat has an even greater relationship with the development of 
hypertension (57). 
 
Sodium Metabolism: 
 The major extra cellular fluid particles are sodium and its accompanying anions 
chloride and bicarbonate, whereas potassium and organic phosphate esters (adenosine 
triphosphate, creatine phosphate, and phospholipids) are the predominant intracellular 
fluid osmoles. Since sodium is largely restricted to the extra cellular compartment, total 
body sodium content is a reflection of the extra cellular fluid volume. 
 
Sodium Balance: 
 Sodium is actively pumped out of cells by the Na + k+ ATPase pump. As a result, 
85 to 90% of all sodium is extra cellular, and the extra cellular fluid volume is a 
reflection of total body sodium content. Changes in sodium concentration generally 
reflect disturbed water homeostasis, whereas alterations in sodium content are manifest as 
extra cellular fluid volume contraction or expansion and imply abnormal sodium balance. 
 
Sodium Intake: 
 Individuals eating a typical western diet consume approximately 150 mmol of 
sodium chloride daily. This normally exceeds basal requirements. Therefore dietary 
intake of sodium results in extra cellular fluid volume expansion, which in turn promotes 
enhanced renal sodium excretion to maintain steady state sodium balance. 
 
Sodium Excretion: 
 The regulation of sodium excretion is multifactorial and is the major determinant 
of sodium balance. Tubule sodium reabsorption is the major regulatory mechanism 
controlling sodium excretion. Almost two-thirds of filtered sodium is reabsorbed in the 
proximal convoluted tubule. Further reabsorption (25 to 30%) occurs in the thick 
ascending limb of the loop of Henle via the apical Na+-K+-2Cl¯ co transporter. Distal 
convoluted tubule reabsorption of sodium (5%) is mediated by the thiazide-sensitive 
Na+-Cl¯ cotransporter. Final sodium reabsorption occurs in the cortical and medullary 
collecting ducts; the amount excreted being reasonably equivalent to the amount ingested 
per day. 
 
Sodium and Hypertension: 
1. Sympathetic Nervous System and Renal Sodium Handling: 
The renal sympathetic nervous system directly stimulates sodium reabsorption 
and renin release from the juxtaglomerular apparatus. Several studies have linked 
sympathetic nervous system hyperactivity with greater than normal increases in blood 
pressure in response to a given sodium load (58). Most authorities believe that the 
mechanism by which the kidney causes hypertension is impairment in the excretion of 
sodium (59, 60). This impairment may be related to genetic changes in various sodium 
exchangers in the proximal and distal tubules that result in altered responses to 
stimulation by the sympathetic nervous system and the renin angiotensin aldosterone 
system. 
 
Interventional studies with sodium restriction and / or loading have revealed that 
the blood pressure responses in many hypertensive patients are salt sensitive. Salt loading 
of patients with essential hypertension results in an increase in blood pressure and in a net 
total body sodium accumulation. 
 
2. An increase in cytosolic free sodium concentration in cells of hypertensive patients 
compared with age and sex matched normotensive controls have been documented (61). 
This results from altered activity of the Na+ / H+ antiporter and the Na + / Li+ counter 
transporter. This increase in intra cellular sodium is highly correlated with the presence of 
an elevated diastolic blood pressure. 
 
3. Most patients with essential hypertension have a defect in the pressure natriuresis 
curve, in which higher systemic pressures are required to excrete a sodium load (62). 
 
4. Another mechanism for decreased sodium excretion in patients with essential 
hypertension is an enhancement of tubulo glomerular feed back (63). 
 
5. Alterations in intrarenal vasoactive mediators may be involved in the impairment of 
sodium excretion in patients with essential hypertension. There may be low levels of 
renal vasodilators, such as prostaglandins, dopamine, and nitric oxide as well as elevated 
levels of renal vasoconstrictors such as angiotensin II and adenosine and increased 
activity of the renal sympathetic nervous system. Alterations in the levels of these agents 
could contribute to net sodium reabsorption because of their direct effects on tubular 
sodium transport. 
 
Potassium Balance: 
 Potassium is the major intracellular cation. The normal plasma potassium 
concentration is 3.5 to 5 mmol / L, whereas that inside the cells is about                        
150 mmol / L. therefore, the amount of potassium in the extra cellular fluid is less than 
2% of the total body potassium content. This is due to the principal result of the resting 
membrane potential and is crucial for normal neuromuscular function. The basolateral 
Na+ K+ - ATPase pump actively transports potassium in and sodium out of the cell in a 
2:3 ratio, and the passive outward diffusion of potassium is quantitatively the most 
important factor that generates the resting membrane potential. 
 
Potassium Intake: 
 The intake of individuals on an average western diet is 40 to 120 mmol/d 90% of 
which is absorbed by the gastrointestinal tract. Immediately following a meal, most of the 
absorbed potassium enters cells as a result of the initial elevation in the plasma potassium 
concentration and facilitated by the insulin release and basal catecholamine levels. 
 
 
 
Potassium Excretion: 
 Renal excretion is the major route of elimination of dietary and other sources of 
excess potassium. 90% of the filtered potassium is reabsorbed by the proximal 
convoluted tubule and the loop of Henle. Proximally, potassium is reabsorbed passively 
with sodium and water, whereas the luminal Na+ - K+ - 2Cl – co transporter mediates 
potassium uptake in the thick ascending limb of the loop of Henle. Therefore potassium 
delivery to the distal nephron approximates dietary intake. The cell responsible for 
potassium secretion in the late distal convoluted tubule and cortical collecting duct is the 
principal cell.     
 
 Modern life style contributes to excess sodium intake. Since sodium excess is 
associated with fluid restriction and increased blood volume which in turn results in an 
increase in blood pressure especially in salt sensitive individuals. At the same time 
modern living with refined food leads to reduced potassium consumption. Hence there is 
a need to study sodium and potassium levels among newly detected essential 
hypertension from different parts of India to find out the true scenario and the status. The 
present report provides an insight into one of its kind from South India.  
 
 
 
 
 
 
AIMS & OBJECTIVES 
 
1. To study the levels of sodium and potassium in patients with primary 
hypertension. 
 
2. To correlate the sodium and potassium levels with blood pressure. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MATERIALS AND METHODS 
 
Setting   : The work was carried out in the outpatient department and medical  
     wards of Govt. Rajaji Hospital, Madurai. 
Design of the study   : Analytical study 
Period of the Study   :  One year – February 2005 to January 2006 
Sample size   : 100 cases (70 cases and 30 controls) 
Ethical committee approval   : The present project was approved by the ethical 
committee. 
Inclusion criteria: 
1. Patients with primary hypertension. 
2. Patients whose age was above 18 years were included. 
3. Both sexes were included. 
Exclusion Criteria: 
1. Patients below 18 years. 
2. Patients with renal failure. 
3. Pregnancy. 
4. Patients with secondary hypertension. 
5. Patients on non-steroidal anti-inflammatory agents, antihypertensives, diuretics, 
beta blockers or stimulants. 
6. Patients with malignant hypertension. 
7. Females on oral contraceptive medication. 
8. Patients with peripheral vascular disease. 
9. Patients with diabetes mellitus. 
10. Patients with acute diarrhoeal diseases. 
 
Consent: 
 The study group thus identified by the above criteria (inclusion and exclusion 
criteria) was first instructed about the nature of the study. Willing participants were taken 
up after getting a written informed consent from them. 
 
Study Subjects and Controls: 
 Seventy newly diagnosed essential hypertensive patients attending the medicine 
OPD or admitted to the medical wards of Govt. Rajaji Hospital for the period of one year 
from February 2005 to January 2006 formed the study group. Thirty healthy people were 
kept as controls. This control group comprised of normotensive individuals who were 
attendants of patients with primary hypertension living in the same environment other 
than their own siblings. 
 
Details of the Study Subjects: 
 All the patients were subjected to detailed history taking, careful physical 
examination and biochemical analysis to exclude secondary hypertension. 
  
 Patient’s height and weight were measured. The body mass index was calculated 
using the formula weight / height ². Patient’s hip and waist circumferences were 
measured. All the peripheral pulses were checked with special attention to carotid and the 
femoral to detect evidence for early atherosclerosis. An ocular fundus examination was 
done to detect hypertensive retinopathy. 
 
Patients were informed to refrain from smoking or drinking tea or coffee for at 
least thirty minutes before measuring blood pressure. Then blood pressure was measured 
using the following guidelines. 
 
Guidelines for measuring blood pressure: 
I     CONDITIONS FOR THE PATIENT 
A. Posture: 
1. Sitting postures are usually adequate for routine follow-up. Patient 
should sit quietly with back supported for five minutes and arm 
supported at the level of heart. 
2. For patients who are over 65, diabetic or receiving anti-hypertensive 
therapy, check for postural changes by taking readings immediately 
and 2 minutes after the patient stands. 
 
B. Circumstances: 
1. No caffeine for preceding hour 
2. No smoking for preceding 15 minutes. 
3. No exogenous adrenergic stimulants like phenylephrine in nasal 
decongestants or eye drops for papillary dilation. 
4. A quite, warm setting. 
5. Home readings taken under various circumstances and 24 hour 
ambulatory recordings may be preferable. 
 
II     EQUIPMENT: 
A. Cuff Size: 
 The bladder should encircle and cover 2/3rds of the arm length. If not, 
place the bladder over the brachial artery; if bladder is small spuriously high 
readings may result. 
 
B. Manometer: 
1. Aneroid gauges should be calibrated every six months against the 
mercury manometer. 
2. For infants use ultrasound equipment e.g., the Doppler method. 
 
III     TECHNIQUE: 
A. Number of readings: 
1. On each occasion, take at least two readings, separated by as much 
time as practical. If readings vary by more than 5 mm Hg, take 
additional readings until two are close. 
2. For diagnosis, obtain at least three sets of readings a week apart. 
3. Initially, take pressure in both arms, if pressure differs, use arm with 
higher pressure. 
4. If arm pressure is elevated, take pressure in one leg, particularly in 
patients below age 30. 
 
B. Performance: 
1. Inflate the bladder quickly to a pressure 20 mm Hg above the systolic, 
as recognized by the disappearance of the radial pulse. 
2. Deflate the bladder 3 mm Hg every second. 
3. Record the Korotkoff phase V (disappearance) except in children, in 
whom use of phase IV (muffling) is advocated. 
4. If Korotkoff sounds are weak, have the patients raise the arm, open 
and close the hand 5 to 10 times, after which the bladder should be 
inflated quickly. 
 
C. Recording: 
 Note the pressure, patient position, the arm, cuff size (e.g., 140/90, seated, 
right arm, large adult cuff). 
 
Urine albumin, sugar, microscopy and pH were done for all the subjects. A twelve 
lead electrocardiogram and chest x ray were also taken.  
 
Overnight (12 hour) fasting blood sugar and urea was done by using Diacetyl 
monoxime (DAM) technique. Serum creatinine was estimated using COBAS auto 
analyzer. Serum sodium and potassium was estimated using Flame emission photometric 
method. 
 
DEFINITIONS USED IN THE PRESENT STUDY: 
Essential Hypertension: 
Hypertension was defined in accordance to the JNC- VII report as systolic blood 
pressure 140 mm of Hg and above and or diastolic blood pressure 90 mm of Hg and 
above. The diagnosis that the hypertension is essential and not secondary was made on 
the overall clinical impression only. Laboratory investigations to rule out secondary 
causes were not done in each case. 
 
Sodium and Potassium Normal Values: 
The normal range for serum sodium was from 135 to 150 mmol / L. The normal 
range for serum potassium was from 3.5 to 5 mmol / L.  
 
Obesity: 
According to the proposed classification of weight by BMI in adult Asians (55), 
the patients with a BMI <18.5 were classified as underweight, 1.85 – 22.9 were classified 
as normal, ≥ 23 were classified as overweight and ≥ 25 were classified as obese. 
 
 
 
 
Diabetes Mellitus: 
 Patients with fasting plasma glucose ≥ 126 mg / dl or two hour plasma glucose ≥ 
200 mg / dl or with symptoms of diabetes plus random blood glucose ≥ 200 mg / dl were 
considered to be diabetic. 
 
Left ventricular hypertrophy: 
Based on the electrocardiographic findings, which satisfy either Sokolow-Lyton 
criteria or Cornell voltage criteria (64, 65). 
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Limitations: 
1. Only serum sodium and potassium were done. 
2.  Twenty four hours urinary sodium and potassium and arterial blood gas 
analysis were not done due to technical and financial limitations. Renal 
handling of sodium and potassium was not attempted as it was beyond the 
scope of the present study. 
3. Body water content was not assessed which may alter the sodium and 
potassium levels. 
4. Tissue sodium and potassium was not measured nor correlated with serum 
sodium and potassium levels. 
5. Hormones related to sodium and potassium handling in kidney was not 
estimated. 
6. The salt intake of the patients could not be assessed quantitatively and 
qualitatively because of social constraints. 
 
Statistical Analysis: 
 The collected data was entered in Microsoft excel spread sheet and analysed 
statistically using epidemiological Information package – 2002 developed by centers for 
disease control and prevention, Atlanta in collaboration with World Health Organization. 
Student ‘t’ values were applied for significance. Significance was considered if the ‘p’ 
value was below 0.05. 
 
 
 
 
 
 
 
 
 
 
RESULTS AND OBSERVATIONS 
The total number of subjects included in this study was 100. Among these 100 
subjects, 70 were cases (Hypertensive) and 30 were controls (Normotensive). 
 
Analysis of cases and controls with respect to age: 
 The age of the subjects in the study group ranged from forty to sixty years. The 
mean and standard deviation for the age of the cases and controls were 53.1 ± 5.37 years 
and 51.5 ± 5.38 years respectively. The study group and the control group did not differ 
from each other statistically with reference to age. 
 
 The distribution of the cases and controls in relation to age is provided in the 
Table – IV given below (fig – 1). 
Table – IV 
Distribution of cases and controls in relation to age 
Cases Controls 
Age group 
No % No % 
41 – 50 24 34.3 18 60 
51 – 60 46 65.7 12 40 
Total 70 100 30 100 
Mean 53.1 51.5 
S.D 5.37 5.38 
Fig – 1 
Distribution of cases and controls in relation to age 
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Majority of the patients in both the study and control group lie between 41 and 60 
years. There was no significant difference in the age composition of those with and 
without hypertension in this study. Almost same age group of patients was selected in 
both groups. 
The mean age distribution for the males in the case and control groups was 52.92 
± 5.52 years and 50.28 ± 5.66 years respectively. The mean age distribution for the 
females in the case and control groups was 53.31 ± 5.27 years and        51.8 ± 2.17 years 
respectively. 
 
 
 
 
 
 
 
 
 
 
Gender: 
 Among the 70 cases studied, there were 38 males and 32 females. Among the 30 
controls, there were 20 males and 10 females.  
The details are given in the Table – V provided below and shown in fig - 2. 
Table – V 
Distribution of cases and controls in relation to gender 
Cases Controls 
Sex 
No % No % 
Male 38 54.3 20 66.7 
Female 32 45.7 10 33.3 
Total 70 100 30 100 
 
 
 
 
 
 
fig – 2 
Distribution of cases and controls in relation to gender 
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Analysis of cases and controls with respect to Body Mass Index (BMI) 
 34.3% of cases were obese while in the control group obesity was noticed in 
3.3%. The details are shown in the Table – VI given below (fig – 3). 
Table – VI 
Distribution of cases and controls with respect to Body Mass Index (BMI) 
Cases controls 
BMI 
No % No % 
Underweight <18.5 7 10 3 10 
Normal weight 18.5 – 22.9 24 34.3 20 66.7 
Overweight 23 – 24.9 15 21.4 6 20 
Obese > 25 24 34.3 1 3.3 
Total 70 100 30 100 
 
 
 
 
 
Fig – 3 
Distribution of cases and controls with respect to  
Body Mass Index (BMI) 
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The mean body mass index in the case group is 23.73 ± 3.28 and in the control 
group is 21.36 ± 2.12. The details are given in the Table – VII given below (fig – 4). 
Table – VII 
BMI among cases and controls 
BMI Cases Controls 
Mean 23.78 21.36 
S.D. 3.28 2.12 
‘p’ value = 0.00004 
This shows that the difference in Body Mass Index between cases and controls 
was statistically significant. 
 
 
 
 
 
 
 
Fig – 4 
BMI among cases and controls 
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The mean BMI of cases and controls according to gender is given in the        
Table – VIII below (fig – 5). 
Table – VIII 
BMI of cases and controls with respect to gender 
Male Female 
Group 
Mean S.D. Mean S.D 
Cases 23.78 3.49 23.68 3.07 
Controls 20.9 1.62 23.62 2.21 
 
 
 
 
 
 
 
 
 
Fig – 5 
BMI of cases and controls with respect to gender 
 
 
 
19
19.5
20
20.5
21
21.5
22
22.5
23
23.5
24
Male Female
Case Control
23.78
20.9
23.6823.62
 
 
 
 
BMI in relation to the grading of hypertension is furnished in the Table – IX 
given below (fig – 6). 
Table – IX 
BMI with respect to Hypertension 
Grade I Hypertension Grade II Hypertension 
BMI 
No. % No. % 
Underweight <18.5 - - 6 8.6 
Normal 18.6 – 22.9 5 7.1 20 28.6 
Overweight 23 – 24.9 4 5.7 11 15.7 
Obese >25 2 2.9 22 31.4 
  
 Body mass index was independent of gender and electrolyte status, but it was 
significantly more in those with grade II hypertension. 
 
 
 
 
Fig – 6 
BMI with respect to Hypertension 
 
 
 
0
5
10
15
20
25
< 18.5 18.5 -
22.9
23 -
24.9
> 25
Grade I Grade II
0
6
5
20
4
11
2
22
 
 
 
 
 
 
 
Analysis of cases with respect to presenting symptoms 
 The most common presenting symptom is giddiness. The other symptoms were in 
the order of headache, chest pain, palpitation and dyspnoea. The details of the presenting 
symptoms are given in the Table – X given below (fig – 7). 
Table – X 
Analysis of presenting symptoms 
Male Female 
Symptoms 
No. % No. % 
Nil 1 1.4 1 1.4 
Headache 7 10 1 1.4 
Giddiness 18 25.7 19 27.1 
Chest pain 6 8.6 3 4.3 
Palpitation 4 5.7 8 11.4 
Dyspnoea 2 2.9 - - 
 
 
 
Fig – 7 
Analysis of presenting symptoms 
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 History of headache and chest pain was noticed among men and these patients 
were suffering from very high blood pressure. In contrast history of palpitation was 
elicited more among women. 
Distribution of cases and controls with respect to cardio vascular risk factors 
 Analysis of other risk factors like smoking, alcoholism and family history were 
done among hypertensives. Their details are furnished in the Table – XI below. 
Table – XI 
Risk factors among cases and controls 
 Smoking Alcohol Both Family history 
 Yes No Yes No  Yes No 
Cases 27 43 10 60 8 10 60 
Control 14 16 6 24 8 - 30 
 
 Since alcoholism and smoking were noticed among men only in this part of the 
country, statistical analysis was not attempted for these risk factors. 
 
 
 
 
 
 
 
 
Blood pressure distribution among cases 
 The details of the blood pressure distribution are given in the Table – XII given 
below (fig – 8). 
 
Table – XII 
Distribution of systolic and diastolic blood pressure 
Cases Control 
Blood Pressure 
Mean + SD Mean + SD 
Systolic 172.14 ± 15.12 106.53 ± 6.37 
Diastolic 103.29 ± 6.07 71.4 ± 4.24 
 
 
 
 
 
 
 
 
 
 
 
Fig – 8 
Distribution of systolic and diastolic blood pressure 
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 The mean systolic blood pressure for the cases was 172.14 ± 15.12 mm Hg. 
Similarly the mean diastolic blood pressure for the cases was 103.29 ± 6.07 mm Hg. 
Since the systolic and diastolic blood pressure was elevated in cases and it was due to the 
nature of the disease taken into study, the statistical analysis was not done. 
 
 The mean systolic and diastolic blood pressure distribution for the males was 
172.63 ± 16.71 mm Hg and 103.42 ± 7.08 mm Hg respectively. Similarly for the females 
the mean systolic and diastolic blood pressure distribution was 171.56 ± 13.22 mm Hg 
and 103.13 ± 4.71 mm Hg respectively. There was no statistical significance in the 
systolic and diastolic blood pressure among the cases. 
  
The distribution of cases with respect to grading of hypertension is given in the 
Table – XIII given below (fig – 9). 
 
Table – XIII 
Distribution of cases with respect to grading of hypertension 
 
Grade I Grade II 
Subject 
No % No % 
Cases 11 15.7 59 84.3 
 
 
 
 
Fig – 9 
Distribution of cases with respect to grading of hypertension 
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Distribution of cases and controls in relation to serum sodium 
Serum sodium in the study population varied from 132 to 158 mmol / L and in the 
control from 136 to 146 mmol / L. The mean and standard deviation of serum sodium 
among cases was 145.41 ± 5.55 mmol / L while in the control group it was                
139.9 ± 3.21 mmol / L respectively. This table clearly shows that the serum sodium level 
was significantly more among hypertensive population studied. 
 
The details are shown in the Table – XIV given below (fig – 10). 
 
Table – XIV 
Serum Sodium levels in cases and controls 
Case Control 
Mean SD Mean SD 
‘p’ value Serum 
Sodium 
145.41 5.55 139.9 3.21 0.000001 
 
 
 
 
 
 
 
 
 
Fig – 10 
Serum Sodium levels in cases and controls 
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Serum sodium in relation to gender 
 The mean value of serum sodium was 146.21 ± 4.81 mmol / L in males and    
144.47 ± 6.27 mmol / L in females among cases. The mean value of serum sodium was 
139.92 ± 3.38 mmol / L in males and 139.8 ± 2.49 mmol / L in females among controls. 
This is shown in Table – XV given below (fig – 11). 
 
Table – XV 
Serum Sodium values in relation to gender 
 
Sex Case Control 
Male 146.21 139.92 
Female 144.47 139.8 
 
 
 
 
 
 
 
 
 
 
 
Fig – 11 
Serum Sodium values in relation to gender 
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 The mean serum sodium level though appeared to be more among males, the 
difference among males and females was not significant statistically. 
 
Distribution of cases and controls in relation to serum potassium 
Serum potassium in the study population varied from 3.1 to 5.2 mmol / L and in 
the control from 3.8 to 4.8 mmol / L. The mean and standard deviation of serum 
potassium among cases was 4.03 ± 0.49 mmol / L while in the control group it was     
4.29 ± 0.33 mmol / L respectively. This table clearly shows that the serum potassium 
level was significantly lower among the hypertensive population studied. 
 
 The details are given in Table – XVI given below (fig – 12). 
 
Table – XVI 
Serum potassium level in cases and controls 
 
Case Control 
Mean S.D Mean S.D 
‘p’ value Serum 
Potassium 
4.03 0.49 4.29 0.33 0.0026 
 
 
 
 
 
 
 
 
 
Fig – 12 
Serum potassium level in cases and controls 
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Serum potassium in relation to gender 
 The mean value of serum potassium was 4.08 ± 0.49 mmol / L in males and    
3.98 ± 0.50 mmol / L in females among cases. The mean value of serum potassium was 
4.26 ± 0.32 mmol / L in males and 4.22 ± 0.40 mmol / L in females among controls. This 
is shown in Table – XVII given below (fig -13). 
 
Table – XVII 
Serum potassium values in relation to gender 
 
Sex Cases Controls 
Male 4.08 4.26 
Female 3.98 4.22 
 
 
 
 
 
 
 
 
 
 
 
Fig – 13 
Serum potassium values in relation to gender 
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 The mean serum potassium level though appeared to be more among males, the 
difference among males and females was not significant statistically. 
 
 Urinary analysis was not contributory. Blood glucose, blood urea and serum 
creatinine were well within acceptable limits and did not differ from healthy control. 
 
 Electrocardiogram revealed left ventricular hypertrophy in about 20 percent of 
study group. Chest X ray showed cardiomegaly in about 16 percent of cases only. Ocular 
fundus examination revealed hypertensive retinopathy in about 38 percent of the study 
group. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DISCUSSION 
 
Hypertension is one of the leading causes of death and disability among adults all 
over the world. Hypertension the most common form of cardiovascular disease is present 
in nearly 25% of adults and increases in prevalence with age. It remains the major risk 
factor for coronary, cerebral and peripheral vascular disease. Essential hypertension 
comprises more than 90% of hypertension (1).  
  
 Patients were studied on the basis of clinical parameters and simple biochemical 
investigations. Serum sodium and potassium was done for all the patients. 
 
Serum sodium among Hypertensives: 
 In our part of the country, there is excessive intake of dietary salt. But in spite of 
that not everyone has essential hypertension. The rarity of hypertension among those 
consuming large amount of salt may probably be related to chronic adaptation of body 
system towards renal clearance of sodium. However this aspect of chronic adaptation of 
sodium handling by kidneys requires further molecular studies. So in addition to the 
hereditary predisposition and high sodium intake and lower potassium intake, the renal 
handling of these cations also play an important role in the pathogenesis of essential 
hypertension (58-60).   
 
 Salt intake was more in the tropical countries by and large in order to overcome 
sodium loss through sweating. In modern days the consumption of salt is more than 
earlier days in view of various food preparations or a combination of them, as man is 
tuned more to taste of the food. Combination of food materials requires additional salt. 
As a result, people consume more than actually required (2 vs. 8-10 g / day / person). 
Such an amount of salt consumption contributes for the development of hypertension in a 
genetically susceptible population. 
 
In our study the mean serum sodium was estimated in the control and study 
groups. Results were compared with other studies. 
 
 Serum sodium was higher in the hypertensive group than the control group even 
though both were within the normal range. The mean and standard deviation of serum 
sodium among cases was 145.41 ± 5.55 while in the control group it was 139.9 ± 3.21 
respectively. 
  
Our study was supported by Jan et al (2006), Srinagar, Kashmir. In his study, one 
hundred thirty five hypertensive patients and equal number of age and sex matched 
healthy controls were taken for the study. Serum sodium in the hypertensive group was 
140 ± 2.90 while in the control group it was found to be 138.5 ± 1.12.  Serum sodium 
was higher in the hypertensive group than the control group and considered to be a factor 
responsible for the causation or perpetuation of blood pressure (66). 
 
A study was carried out by Lever et al of arterial pressure and body content of 
electrolytes in 91 patients with essential hypertension and 121 normal controls (67). 
Essential 
Hypertension 
Kidney Salt 
Hypothesis 
Dietary Salt 
Hypothesis 
Cell Salt 
Hypothesis 
Plasma and exchangeable sodium was found to be positively correlated with arterial 
pressure in the patients. Three hypotheses were proposed to explain the mechanisms 
relating electrolytes and arterial pressure in essential hypertension and it was depicted in 
pictorial form in figure – 14 shown in the following page. 
1. Cell-salt hypothesis 
2. Dietary salt hypothesis 
3. Kidney-salt hypothesis.  
 
Figure - 14 
Proposed hypotheses by Lever et al in the pathogenesis of essential hypertension 
 
 
 
 
 
 
 
 
 
 
 
 
It was concluded that two mechanisms probably operate in essential hypertension. 
In the early stages of the disease, blood pressure is raised by an abnormal process related 
more closely to potassium than to sodium. A renal lesion develops later, possibly as a 
consequence of the hypertension. This lesion is characterised by resetting of pressure 
natriuresis and is manifest by an abnormal relation between body sodium and arterial 
pressure and by susceptibility to increased dietary sodium intake. 
 In another study conducted by Williams et al, they studied the relationship of 
body sodium, chlorine and potassium in 30 patients with essential hypertension. They 
found that a positive correlation exists between serum sodium and blood pressure in this 
study group (68). 
 
In another study conducted by Nanji et al, it was shown that a positive correlation 
exists between serum sodium and hypertension (69).  
 
A study was conducted among Japanese people by Komiya et al. They studied 
3222 normal Japanese subjects (610 in Kashiwa City Hospital and 2612 in Shinshu 
University Hospital), 741 Japanese patients with essential hypertension (256 in Kashiwa 
City Hospital and 485 in Shinshu University Hospital) to determine the possible roles of 
sodium, renal function, and plasma aldosterone concentration (PAC) on blood pressure 
elevation.. They found that the peak of the serum sodium distribution curve was 
approximately 2 mmol / L higher in the hypertensive group as compared with that in the 
control group. The prevalence of higher serum sodium concentration (> or = 147 mmol/l) 
was also significantly higher in the hypertensive group (70). 
 In another study conducted by Bulpitt, two thousand, three hundred and twenty-
eight men and 1496 women between the ages of 35 and 64 years were screened for 
hypertension and their plasma sodium and potassium concentrations measured. It was 
found that plasma sodium was positively related to that of blood pressure and an increase 
in serum sodium of 1 mmol / L was associated with an increase of 1 mm of Hg in both 
men and women (71). 
 
Serum potassium among Hypertensives:  
In our study serum potassium was estimated in control and study groups and 
compared between them. Serum potassium was found to be lower in the hypertensive 
group when compared with the control group even though both were within the normal 
range. 
 
 The mean serum potassium in the study group was 4.03 ± 0.49. The mean 
potassium in the control group was 4.29 ± 0.33. 
  
A study was carried out by Bulpitt et al among two thousand, three hundred and 
twenty-eight men and 1496 women between the ages of 35 and 64 years and were 
screened for hypertension and their plasma sodium and potassium concentrations 
measured. Those on antihypertensive or diuretic treatment were excluded from further 
analysis. After adjusting for age, body mass index and other variables, plasma potassium 
was negatively associated with both systolic and diastolic pressure in men and women. A 
decrease in plasma potassium of 1 mmol/l was associated with an increase in systolic 
pressure in women of 7 mmHg (P less than 0.001) and diastolic pressure of                      
4 mmHg (P less than 0.001). In men the corresponding increases were 4 mmHg (P less 
than 0.01) and 2 mmHg (P less than 0.05) (71). 
 Similarly in a study conducted by Lever et al in 121 normal subjects and 91 
hypertensive patients, it was shown that plasma, exchangeable, and total body potassium 
correlated inversely with arterial pressure in the patients. They have suggested the 
following theory as the cause of essential hypertension. In the early stages of the disease 
blood pressure is raised by an abnormal process related more closely to potassium than to 
sodium. A renal lesion develops later, possibly as a consequence of the hypertension. 
This lesion is characterised by resetting of pressure natriuresis and is manifest by an 
abnormal relation between body sodium and arterial pressure and by susceptibility to 
increased dietary sodium intake (67). 
 
Similarly a study was conducted at National Institute of Public Health and 
Environmental Protection, Bilthoven, The Netherlands. The relationships between the 
serum cations sodium, potassium, calcium and magnesium and blood pressure were 
investigated in a population-based sample of 182 Dutch persons aged 20-59 years. In the 
combined analysis, a weak inverse relationship was found between serum potassium and 
diastolic blood pressure; this relationship was also found in women (72). 
 
In an another study carried out at Karachi, Pakistan, thirty hypertensive diabetic 
patients and equal number of age and sex matched controls were taken for the study. The 
mean serum potassium was 4.59 mmol / l among the study group while 5.03 mmol / l 
among the control group (73). 
 
In a study carried out at the University of Tokyo, they measured plasma 
electrolytes in 82 essential hypertensive patients to examine the relation between blood 
pressure and plasma electrolytes. Significant negative correlations were observed 
between plasma potassium concentration and 24-h systolic blood pressure (r = -0.336) 
and diastolic blood pressure (r = -0.298) in their patients. Plasma potassium concentration 
inversely correlated also with both daytime and nighttime systolic and diastolic blood 
pressure. There was no relation between office blood pressure and plasma potassium 
concentration. These findings indicate that in essential hypertensives plasma potassium 
concentration is inversely related to ambulatory blood pressure including daytime and 
nighttime blood pressure and suggest that potassium may be a factor determining the 
whole day blood pressure in essential hypertension (74). 
 
To investigate the role of potassium on blood pressure Luft et al, conducted a 
study among 431normotensive and 478 hypertensive subjects. They observed an inverse 
relationship between serum potassium and blood pressure supporting our study (75). 
 
BMI and Hypertension:  
In our study the mean BMI among the study group was 23.73 ± 3.28 and among 
the control group was 21.36 ± 2.12. The ‘p’ value was .00004. This shows that 
overweight and obesity also plays a role in the development of essential hypertension. 
 This was supported by a study conducted by Stamler (54). They showed that the 
hypertension is about six times more common in obese than it is in lean subjects. The 
present study concurs with above observation. However body mass index was not related 
to electrolyte levels. 
 
 Similarly a study conducted by Huang stated that even a small amount of weight 
gain is associated with a marked increase in the incidence of hypertension (76). This 
study showed a positive correlation between BMI and blood pressure which supported 
our study. 
 
In INTERSALT, the relationship between body mass index (kg/m2) and blood 
pressure was studied in 10,079 men and women aged 20-59, sampled from 52 centres 
around the world, based on a standardized protocol with central training of observers, a 
central laboratory and extensive quality control. Body mass index-blood pressure 
relationships were first studied in men and women within each centre, and results of these 
regression analyses were then pooled for all 52 centres. With adjustment for age, alcohol 
intake, smoking, and sodium and potassium excretion, body mass index was positively 
associated with systolic blood pressure among men in 51 of 52 centres and among 
women in 47, significantly so in 24 and 27, respectively. Body mass index was positively 
associated with diastolic blood pressure in 51 and 49 centres in men and women, 
respectively, significantly so in 33 and 31. Overall, a 10 kg difference in body weight was 
associated on average with a 3.0 mmHg difference in systolic and a 2.2 mmHg difference 
in diastolic pressure. In further analyses across centres, median body mass index was 
related significantly to median systolic blood pressure, median diastolic pressure and the 
prevalence of hypertension in both men and women. Body mass index was related to the 
slopes of systolic and diastolic blood pressure with age in women, but not in men (77). 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Areas for further research 
1. To identify the markers of hypertension prone population. 
2. To find out the genes responsible for renal sodium handling and if required to 
develop a biomolecule to overcome the effects of the mediators of which signal / 
control the sodium and potassium at the molecular level. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CONCLUSION 
 
The following conclusions were derived from our study. 
 
1. Serum sodium was significantly more among hypertensives and it was 
independent of associated risk factors and gender. 
 
2. Serum sodium level was also correlated positively with the level of blood 
pressure. 
 
3. Serum potassium was significantly less among hypertensives and it correlated 
negatively with blood pressure. 
 
4. Serum sodium and potassium were independent of body mass index. 
 
5. In view of the significant changes in simple electrolyte levels (sodium and 
potassium) among hypertensive population, community must be motivated to 
reduce their intake of common salt and encouraged to consume potassium rich 
nutrients – diets as a form of primary prevention for essential hypertension. 
 
 
 
 
SUMMARY 
 
 Essential hypertension is the major risk factor for coronary, cerebral and renal 
vascular diseases. Etiology for essential hypertension is not known. Many theories were 
postulated. 
 
The present study attempts to focus the serum sodium and potassium level among 
isolated newly diagnosed essential hypertensives who were free from any other illnesses 
or under any medication and to correlate electrolyte status with the blood pressure. 
Fasting serum sodium and potassium were estimated (flame photometer) in seventy 
hypertensives (m=38, f=32; mean age 53.1 ± 5.37) and thirty healthy controls (m=20 
f=10; mean age 51.5 ± 5.38). Efforts were also made to find out an association between 
body mass index and waist circumference with systolic and diastolic blood pressure. 
Body mass index was significantly more in those with stage II hypertension. However it 
was independent of gender and electrolyte status.  Mean serum sodium level was elevated 
significantly (‘p’ = 0.000001) among hypertensives where as serum potassium level was 
significantly lower among them when compared to healthy controls. The blood pressure 
also correlated positively with serum sodium; body mass index and waist circumference 
where as negatively correlated with serum potassium. 
 
Changing life styles have modified the food habits, making people to consume 
food rich in sodium but low in potassium. As a result genetically susceptible population 
when exposed to high sodium content coupled with low potassium in their diet, 
hypertension becomes overt. The possible mechanisms were discussed. 
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⁯ Vomiting / Hiccups  ⁯ Palpitation  ⁯ Easy fatiguability 
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PAST HISTORY 
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0 
19
0 
19
0 
18
0 
18
0 
19
0 
16
0 
17
0 
16
0 
18
0 
17
0 
19
0 
15
0 
16
0 
18
0 
18
0 
Fundus N
 
N
 
I I N
 
I I N
 
N
 
N
 
I N
 
I N
 
I I N
 
WHR 
0.
8 
1 0.
91
 
1 0.
82
 
0.
95
 
0.
91
 
0.
95
 
0.
96
 
0.
9 
0.
93
 
0.
93
 
0.
94
 
0.
94
 
0.
95
 
0.
89
 
0.
91
 
BMI 
24
.3
 
27
.5
 
21
.7
 
24
.8
 
24
 
26
.4
 
29
.2
 
28
.8
 
29
.3
 
25
.1
 
22
.3
 
29
.9
 
27
.3
 
22
.8
 
27
.7
 
23
.8
 
21
.7
 
F / H N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
H
 
N
 
N
 
N
 
N
 
N
 
N
 
H
 
Alcohol 
N
o 
N
o 
Y
 
N
o 
N
o 
N
o 
N
o 
N
o 
N
o 
N
o 
N
o 
N
o 
N
o 
N
o 
N
o 
N
o 
N
o 
Smoking 
N
o 
N
o 
Y
 
N
o 
N
o 
Y
 
N
o 
N
o 
Y
 
N
o 
Y
 
Y
 
N
o 
N
o 
Y
 
N
o 
N
o 
P / H N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
Symptoms 2 1 2 2 2 3 2 4 2 2 2 3 2 1 1 1 1 
Age / Sex 
43
/F
 
56
/M
 
55
/M
 
60
/M
 
48
/F
 
54
/M
 
45
/F
 
55
/F
 
46
/M
 
52
/F
 
52
/M
 
56
/M
 
50
/F
 
55
/M
 
48
/M
 
60
/F
 
54
/F
 
Sl. No 
35
 
36
 
37
 
38
 
39
 
40
 
41
 
42
 
43
 
44
 
45
 
46
 
47
 
48
 
49
 
50
 
51
 
 
 
 
 
 
 
 
 
CXR N
 
C
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
ECG N
 
L N
 
N
 
N
 
L N
 
N
 
N
 
N
 
N
 
N
 
L L N
 
N
 
N
 
Sr. 
Potassium 4.
3 
4.
5 
3.
4 
4.
5 
4.
3 
5.
2 
4 4.
8 
3.
6 
5 3.
5 
4.
6 
4.
6 
3.
9 
3.
4 
5 4 
Sr. 
Sodium 14
6 
14
0 
15
0 
14
2 
14
8 
14
2 
14
8 
13
3 
13
4 
13
2 
13
8 
14
1 
13
9 
14
6 
15
3 
14
4 
13
8 
Sr. 
Creatinine 0.
9 
1.
1 
0.
9 
0.
9 
1 1 1.
2 
0.
8 
1.
2 
0.
8 
1.
1 
1.
1 
0.
9 
1.
2 
1.
1 
0.
9 
1 
Bl. Urea 
42
 
32
 
26
 
28
 
18
 
23
 
24
 
28
 
31
 
28
 
32
 
36
 
42
 
43
 
36
 
18
 
20
 
Bl. 
Glucose 10
8 
96
 
84
 
10
5 
10
8 
13
3 
80
 
10
4 
11
2 
92
 
11
2 
10
8 
10
8 
12
0 
92
 
86
 
72
 
UR N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
SE N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
DBP 
10
0 
11
0 
10
0 
11
0 
10
0 
10
0 
10
0 
11
0 
10
0 
11
0 
10
0 
10
0 
10
0 
11
0 
10
0 
10
0 
10
0 
SBP 
15
0 
19
0 
15
0 
19
0 
17
0 
17
0 
17
0 
17
0 
18
0 
18
0 
17
0 
18
0 
17
0 
20
0 
17
0 
15
0 
17
0 
Fundus N
 
I N
 
I N
 
I N
 
I N
 
N
 
N
 
I N
 
I I N
 
N
 
WHR 
0.
83
 
0.
93
 
0.
92
 
0.
83
 
0.
95
 
0.
98
 
0.
9 
0.
98
 
0.
92
 
0.
9 
0.
85
 
0.
85
 
0.
91
 
0.
91
 
0.
93
 
0.
93
 
1 
BMI 
23
.9
 
22
.9
 
21
.7
 
25
.1
 
25
.5
 
21
.4
 
23
.4
 
25
.6
 
24
.6
 
21
.3
 
23
.2
 
22
.3
 
21
 
23
.8
 
20
.7
 
22
.1
 
25
.5
 
F / H N
 
N
 
H
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
H
 
N
 
N
 
Alcohol 
N
o 
N
o 
Y
 
N
o 
N
o 
N
o 
N
o 
N
o 
N
o 
N
o 
N
o 
N
o 
N
o 
N
o 
Y
 
N
o 
N
o 
Smoking 
N
o 
Y
 
Y
 
N
o 
Y
 
Y
 
N
o 
N
o 
N
o 
N
o 
N
o 
Y
 
N
o 
Y
 
Y
 
N
o 
N
o 
P / H N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
Symptoms 4 2 3 2 1 2 2 4 3 2 2 1 2 2 3 2 2 
Age / Sex 
51
/F
 
60
/M
 
41
/M
 
49
/F
 
49
/M
 
56
/M
 
48
/M
 
54
/F
 
56
/F
 
60
/F
 
60
/F
 
59
/M
 
58
/F
 
52
/M
 
48
/M
 
60
/M
 
54
/F
 
Sl. No 
52
 
53
 
54
 
55
 
56
 
57
 
58
 
59
 
60
 
61
 
62
 
63
 
64
 
65
 
66
 
67
 
68
 
 
 
 
 
 
 
 
 
CXR N
 
C
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
ECG N
 
L N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
Sr. 
Potassium 3.
9 
3.
8 
4 4.
1 
4.
7 
3.
9 
4.
6 
4.
8 
4.
6 
4.
1 
4.
2 
4.
9 
4.
2 
4.
1 
4.
8 
4.
5 
4.
4 
Sr. 
Sodium 14
9 
15
3 
13
6 
13
7 
14
6 
14
0 
14
4 
14
0 
13
8 
14
4 
13
9 
13
4 
14
0 
13
9 
13
8 
13
8 
13
8 
Sr. 
Creatinine 0.
7 
1 0.
8 
0.
7 
0.
7 
0.
8 
0.
7 
0.
8 
0.
8 
0.
7 
0.
8 
0.
7 
0.
6 
0.
7 
0.
8 
0.
8 
1.
2 
Bl. Urea 
20
 
26
 
20
 
21
 
19
 
18
 
20
 
22
 
24
 
20
 
21
 
22
 
16
 
22
 
20
 
20
 
36
 
Bl. 
Glucose 78
 
92
 
73
 
80
 
82
 
90
 
70
 
80
 
84
 
70
 
74
 
84
 
87
 
87
 
99
 
69
 
80
 
UR N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
SE N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
DBP 
10
0 
11
0 
80
 
70
 
70
 
70
 
70
 
80
 
80
 
70
 
70
 
70
 
70
 
70
 
70
 
70
 
70
 
SBP 
17
0 
20
0 
12
0 
11
0 
10
0 
90
 
10
0 
11
0 
11
0 
11
0 
11
0 
11
0 
11
0 
10
0 
10
0 
11
0 
10
0 
Fundus N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
WHR 
0.
88
 
0.
95
 
0.
79
 
0.
81
 
0.
8 
0.
87
 
0.
86
 
0.
97
 
0.
91
 
0.
91
 
0.
88
 
0.
8 
0.
8 
0.
96
 
0.
82
 
0.
83
 
0.
9 
BMI 
18
.2
 
25
.7
 
19
.1
 
20
 
18
.9
 
17
.7
 
17
.3
 
22
.6
 
19
.3
 
20
.2
 
23
.2
 
21
.3
 
26
.4
 
20
.5
 
20
.3
 
19
.8
 
17
.9
 
F / H N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
D
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
Alcohol 
N
o 
N
o 
N
o 
N
o 
Y
 
Y
 
Y
 
N
o 
Y
 
N
o 
N
o 
N
o 
N
o 
Y
 
N
o 
Y
 
Y
 
Smoking 
Y
 
Y
 
N
o 
Y
 
Y
 
N
o 
Y
 
N
o 
N
o 
Y
 
N
o 
N
o 
N
o 
Y
 
N
o 
Y
 
Y
 
P / H N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
Symptoms 2 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Age / Sex 
59
/M
 
52
/M
 
51
/F
 
43
/M
 
45
/M
 
48
/M
 
42
/M
 
46
/M
 
54
/M
 
49
/M
 
50
/M
 
45
/M
 
46
/F
 
56
/M
 
45
/F
 
60
/M
 
55
/M
 
Sl. No 
69
 
70
 
71
 
72
 
73
 
74
 
75
 
76
 
77
 
78
 
79
 
80
 
81
 
82
 
83
 
84
 
85
 
 
 
 
 
 
0 – no symptom 1 – headache  2 – giddiness  3 – chest pain   4 – palpitation   5 – dyspnoea   
Y – Yes N – normal M – male F- female  I – grade I ht retinopathy  L – LVH   
B – LAHB  C – cardiomegaly F/H – family history P/H – past history  
CXR N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
ECG N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
Sr. 
Potassium 4.
6 
4.
7 
4.
1 
4.
2 
3.
8 
4.
2 
4 4.
1 
4.
2 
3.
9 
4.
1 
4.
2 
3.
8 
4.
8 
4 
Sr. 
Sodium 13
6 
13
7 
14
6 
14
5 
14
4 
14
0 
13
8 
14
4 
13
9 
14
4 
14
0 
13
9 
13
8 
13
8 
13
8 
Sr. 
Creatinine 1.
1 
1 1.
1 
0.
8 
0.
6 
0.
9 
0.
8 
1.
1 
0.
8 
1.
1 
1.
1 
1 0.
8 
1.
1 
1.
1 
Bl. Urea 
28
 
32
 
39
 
28
 
30
 
36
 
24
 
28
 
21
 
32
 
36
 
42
 
21
 
42
 
36
 
Bl. 
Glucose 11
3 
10
8 
11
8 
10
8 
96
 
84
 
84
 
11
4 
10
4 
12
0 
10
2 
98
 
10
9 
11
2 
96
 
UR N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
SE N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
DBP 
78
 
60
 
70
 
70
 
74
 
80
 
70
 
70
 
70
 
70
 
70
 
70
 
70
 
70
 
70
 
SBP 
11
6 
10
0 
10
0 
11
0 
11
0 
11
0 
11
0 
11
0 
11
0 
10
0 
11
0 
10
0 
11
0 
10
0 
11
0 
Fundus N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
WHR 
0.
84
 
0.
9 
0.
88
 
0.
87
 
0.
86
 
0.
97
 
0.
97
 
0.
98
 
0.
95
 
0.
8 
0.
98
 
0.
96
 
0.
93
 
0.
94
 
0.
9 
BMI 
20
.5
 
23
.7
 
23
 
22
.7
 
21
.2
 
22
.6
 
22
.3
 
22
.9
 
24
.4
 
23
.2
 
21
.2
 
21
.9
 
23
.8
 
22
 
20
.8
 
F / H N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
Alcohol 
Y
 
N
o 
Y
 
N
o 
N
o 
N
o 
N
o 
N
o 
N
o 
N
o 
Y
 
N
o 
N
o 
N
o 
N
o 
Smoking 
Y
 
Y
 
Y
 
N
o 
N
o 
N
o 
N
o 
Y
 
N
o 
N
o 
Y
 
Y
 
N
o 
Y
 
N
o 
P / H N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
N
 
Symptoms 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Age / Sex 
51
/M
 
43
/M
 
45
/M
 
48
/M
 
52
/F
 
53
/F
 
54
/F
 
62
/M
 
50
/F
 
45
/F
 
46
/M
 
45
/M
 
48
/F
 
60
/M
 
54
/F
 
Sl. No 
86
 
87
 
88
 
89
 
90
 
91
 
92
 
93
 
94
 
95
 
96
 
97
 
98
 
99
 
10
0 
